Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia is a research paper published in Leukemia (2022). On theSindex it has a DataRank of 1.6. It has been cited 57 times, with 44 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.609
From this paper's citation signal
Citation Network Contribution
1.0
From 31 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 44 citers.
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Grant: Intramural
Intramural NIH HHS
Grant: Z99 HL999999
FWCI
6.68
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis
Additional file 1 of Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis